Primary cutaneous B-cell lymphomas (CBCLs) represent a rare, but distinct group of B-cell neoplasms with a different clinical behaviour to B-cell lymphomas secondarily involving the skin. Fas-Fas ligand (Fasl) expression was investigated in a group of primary and secondary CBCLs to gain an insight i
Fas and Fas ligand: expression and soluble circulating levels in cutaneous malignant melanoma
✍ Scribed by P. Redondo; T. Solano; B. VÁzquez; A. Bauza; M. Idoate
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 350 KB
- Volume
- 147
- Category
- Article
- ISSN
- 0007-0963
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Impaired regulation of apoptosis is known to be associated with the development of various cancers. fas receptor (apo-1/cd95) binding to its ligand, fas-ligand (fas-l), has been shown to trigger apoptosis in various cell types. ## Objectives: In this study, we examined cd95 and fas
Fas, a cell surface receptor and member of the tumour necrosis factor receptor superfamily, induces apoptosis upon oligomerization by its ligand (Fas ligand: FasL). Detailed studies have revealed that Fas is broadly expressed in normal human tissues, but relatively little is known about the range of